Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus.
about
Dairy components and risk factors for cardiometabolic syndrome: recent evidence and opportunities for future research.Pharmacological treatment of type 2 diabetes.Co-Ingestion of Whey Protein with a Carbohydrate-Rich Breakfast Does Not Affect Glycemia, Insulinemia or Subjective Appetite Following a Subsequent Meal in Healthy Males.Cardiovascular complications of immunosuppressive agents in renal transplant recipients.A review of nateglinide in the management of patients with type 2 diabetes.How to make a functional β-cellPaediatric diabetes: achieving practical, effective insulin therapy in type 1 and type 2 diabetes.Free Radicals Scavenging Capacity, Antidiabetic and Antihypertensive Activities of Flavonoid-Rich Fractions from Leaves of Trichilia emetica and Opilia amentacea in an Animal Model of Type 2 Diabetes Mellitus.Polyopes lancifolia Extract, a Potent α-Glucosidase Inhibitor, Alleviates Postprandial Hyperglycemia in Diabetic MiceDairy constituents and neurocognitive health in ageing.Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin.Lifestyle impact on meal-induced insulin sensitization in health and prediabetes: a focus on diet, antioxidants, and exercise interventions.Sargassum yezoense Extract Inhibits Carbohydrate Digestive Enzymes In Vitro and Alleviates Postprandial Hyperglycemia in Diabetic Mice.Effects of high-monounsaturated fatty acid enteral formula versus high-carbohydrate enteral formula on plasma glucose concentration and insulin secretion in healthy individuals and diabetic patients.Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor.Lupin and soya reduce glycaemia acutely in type 2 diabetes
P2860
Q35244994-D27628D9-41F5-4747-9C15-BC3A219919B4Q35821479-F1056FF7-D764-464C-B364-D33894C19A61Q35939803-66D8D73A-9131-4B10-947C-FF9A811FE28DQ36040739-ED7D7FEC-1EA7-4819-8F27-F2BA3BFB224FQ36596836-0E51C25D-1D1D-49DC-A8F7-E266A0E2E7F1Q36883210-C06A815A-4A34-45FC-B600-C95F1E2E0BAFQ36971945-5CE20CDF-0162-4711-A992-1FAD299FBD17Q37588105-8DF63293-6C44-42D3-AAC4-A675593B4AABQ37723537-635B14E9-29C8-43EC-9820-23FE66A6339FQ37845454-325C0280-A06F-4C22-94B3-5FF42B52B0FCQ37857686-957B68AA-BD96-4B8C-81D7-26AEC62934FCQ38086281-A148EF50-2435-4609-8AF6-B83F5D286192Q42378588-55ACDFE2-32A1-4A30-9FE7-7148EB4FFCA2Q46784635-CA8F9ED7-0F32-4B61-BE56-C7EF87189869Q47615563-2D4B3F76-C784-4F96-A42D-5255D0BDB1D7Q57095268-26C49998-FD5C-4DFA-BEC8-3CBA2EDD892D
P2860
Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Clinical significance of targe ...... ging type 2 diabetes mellitus.
@ast
Clinical significance of targe ...... ging type 2 diabetes mellitus.
@en
type
label
Clinical significance of targe ...... ging type 2 diabetes mellitus.
@ast
Clinical significance of targe ...... ging type 2 diabetes mellitus.
@en
prefLabel
Clinical significance of targe ...... ging type 2 diabetes mellitus.
@ast
Clinical significance of targe ...... ging type 2 diabetes mellitus.
@en
P1476
Clinical significance of targe ...... ging type 2 diabetes mellitus.
@en
P2093
Vivian Fonseca
P304
P356
10.1185/030079903125002351
P407
P577
2003-01-01T00:00:00Z